Filing status
- Accounts due
- 31 December 2027
- Last accounts
- 31 March 2026
- Conf. stmt due
- 13 March 2027
- Last conf. stmt
- 27 February 2026
Implexis Ltd
- Incorporated
- 6 March 2025 (1 year)
- Industry
- Manufacture of pharmaceutical preparations (21200) Business and domestic software development (62012)
- Directors
- Youssef Wael Badreldin Mahmoud Abdalla
- Owned by
- Youssef Wael Badreldin Mahmoud Abdalla
- Accounts type
- Micro entity
- Region
- Greater London
- Address
- London Innovation CentreLab 21Floor 520 Water StreetLondonE14 5GX
Officers
This list may be incomplete. See all officers on Companies House
Officer details are public data from the Companies House register.
Corporate Director · Appointed 16 June 2026
Also at Morrigan Therapeutics Limited (proposed for strike-off), Focalis Bio Limited
Abdalla, Youssef Wael Badreldin Mahmoud, Dr
Director · Appointed 6 March 2025
British
Born March 1998 (28)
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Youssef Wael Badreldin Mahmoud Abdalla
Individual · Notified 6 March 2025
Owns 25–50% of shares
Holds 25–50% of voting rights
British
Born March 1998 (28)
Former controllers (2)
14 October 2025
Ceased Michael Thomas Cook — Owns 25–50% of shares
14 October 2025
Ceased David Robert Shorthouse — Owns 25–50% of shares
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 2 November 2026 | Director's details changed | |||
| 2 November 2026 | Director's details changed | |||
| 23 October 2026 | Micro company accounts | 31 March 2026 |
Other companies in this industry
Castleford
Runcorn
Northampton
Oxford
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →